跳至主導覽
跳至搜尋
跳過主要內容
國立中央大學 首頁
說明與常見問題
English
中文
首頁
人才檔案
研究單位
研究計畫
研究成果
資料集
榮譽/獲獎
學術活動
新聞/媒體
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
李 宇翔
教授, 主任秘書
生醫科學與工程學系
電子郵件
yuhsianl
ncu.edu
tw
網站
http://dbse.ncu.edu.tw/index.php/ch/faculty/faculty_more/id/14.html
h-index
1027
引文
13
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2026
每年研究成果
概覽
指紋
網路
研究計畫
(26)
研究成果
(43)
資料集
(3)
類似的個人檔案
(5)
指紋
查看啟用 Yu-Hsiang Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Acne Vulgaris
14%
Acoustic Field
34%
Anti-human Epidermal Growth Factor Receptor 2
24%
Biological Evaluation
34%
Breast Cancer Cells
34%
Camptothecin
14%
Co-load
37%
Composite Hydrogel
17%
Cutibacterium Acnes (C. acnes)
20%
Delivery Efficiency
20%
Diabetic Wound Healing
22%
Double Nanoemulsion
22%
Epidermal Growth Factor
20%
Field Exposure
18%
Fluorocarbon
17%
Gene Delivery
37%
Growth Factors
17%
Human Bladder Cancer Cells
22%
Human Epidermal Growth Factor Receptor 2 (HER2)
28%
Indocyanine Green
100%
Laminar Shear Stress
40%
Marine Microalgae
22%
Microalgae Cultivation
15%
Microalgae Growth
22%
Microalgal Growth
22%
Nannochloropsis
31%
Nanodroplets
16%
Nanoparticles
32%
Near-infrared
15%
Nicotine
22%
Nodal Plane
30%
Non-viral Gene Delivery
22%
Oxygen Carrier
22%
Perfluorocarbon
52%
Perfluorocarbon Emulsion
21%
Perfluorocarbon Nanodroplets
22%
Photobioreactor System
34%
Photochemotherapy
54%
PLGA Nanoparticles
14%
Polyethylene Glycol
15%
Polyethyleneimine
20%
Resonant Acoustic
34%
Retroviral Transduction
41%
Retrovirus
40%
Rifampicin
31%
Saliva
27%
Singlet Oxygen
14%
Synthetic Evaluation
22%
Translational Biomarkers
22%
Ultrasound Field
22%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
15%
Ascorbic Acid
11%
Bladder Cancer
34%
Breast Cancer
35%
Calcein
11%
Carbon Dioxide
22%
Cardiovascular Disease
15%
Chitosan
17%
Cigarette Smoke
11%
Diabetes Mellitus
28%
Diseases
13%
Doxorubicin
14%
Drug Carrier
11%
Endothelial Dysfunction
15%
Endothelium Injury
11%
Epidermal Growth Factor
13%
Epidermal Growth Factor Receptor
11%
Epidermal Growth Factor Receptor 2
28%
Fluorocarbon
88%
Gamma Urogastrone
28%
Gene Delivery
37%
Growth Factor
17%
Hemostatic Agent
11%
Indocyanine Green
82%
Infectious Arthritis
11%
Inflammation
20%
Macrogol
26%
Malignant Neoplasm
41%
Microalga
37%
Microcarrier
11%
Microsphere
11%
Mitomycin
11%
Nannochloropsis Oculata
14%
Nanocomposite
11%
Nanoemulsion
43%
Nanomaterial
16%
Nanoparticle
51%
Perfluoro Compound
11%
Perfluoropentane
11%
Photodynamic Therapy
48%
Polyethylene Glycol
11%
Polyethyleneimine
19%
Polyglactin
20%
Retrovirus
42%
Rifampicin
20%
Singlet Oxygen
13%
Sonoporation
14%
Transcriptome
11%
Wound
18%
Wound Healing
22%
Medicine and Dentistry
Acne Vulgaris
14%
Antimicrobial Therapy
11%
Biological Marker
27%
Bladder
11%
Bladder Cancer
34%
Bone Morphogenetic Protein Receptor
11%
Breast Cancer
28%
Cancer Cell
57%
Cancer Therapy
10%
Cell Cycle Arrest
11%
Cell Cycle Checkpoint
11%
Cell Growth
10%
Cell Migration
11%
Cytoskeleton
11%
Diabetic Wound
11%
Diseases
13%
Doxorubicin
14%
Endothelial Cell
22%
Epidermal Growth Factor Receptor
13%
Epidermal Growth Factor Receptor 2
22%
Fluorocarbon
61%
Gamma Urogastrone
22%
Gene Expression Profiling
11%
Hemodynamic
11%
Hemostat
11%
Human Umbilical Vein Endothelial Cell
11%
Hyperglycemia
8%
In Vitro
21%
Indocyanine Green
63%
Malignant Neoplasm
20%
Maturity Onset Diabetes of the Young
11%
Messenger RNA
8%
Metastatic Carcinoma
17%
Mitomycin
11%
Mortality Rate
10%
Nanomaterial
13%
Nanoparticle
25%
Pathogen
11%
Photochemotherapy
40%
Polyethylene Glycol
11%
Polyethyleneimine
11%
Probiotics
14%
Programmed Cell Death
11%
Propionibacterium acnes
20%
Protein Expression
18%
Rifampicin
22%
Transcriptomics
21%
Transitional Cell Carcinoma
11%
Type 2 Diabetes
11%
Wound Healing
11%
